Beike Biotech has once again demonstrated its active contribution to industry standardization. On April 11, 2024, the National Group Standards Information Platform issued an announcement that the "General Requirements for Human-Derived Cell Storage Services" (No.: T/CRHA 041—2024), co-authored with Shenzhen Beike Biotechnology Co., Ltd., has been officially released. The group standard falls under the purview of the Chinese Research Hospital Association and will take effect on April 15, 2024.
T/CRHA 041—2024 "General Requirements for Human-Derived Cell Storage Services" specifies the service providers, service safeguards, service specifications, service-delivery specifications, service quality control specifications, and service quality supervision, evaluation, and improvement requirements for human-derived cell storage services. It applies to the management of organizations or departments providing human-derived cell storage services, but does not apply to the management of organizations or departments providing storage services for hematopoietic stem cells used in transfusion or transplantation, germ cells, or tissue-like and organoid-like products composed of cells.
As one of the co-authoring units of this standard, Beike Biotech was deeply involved in drafting, researching, and developing it. Drawing on its many years of rich experience in cell preparation, storage, and clinical translation, the company provided important technical support and practical reference for the development of the standard. As a national high-tech enterprise specializing in the clinical translation and technical services of biotherapy technologies in strategic emerging industries, Beike Biotech has consistently led with innovation, actively promoting the standardization of the cell industry. The company has cumulatively participated in the development of dozens of national, local, group, and other standards, covering multiple areas of the cell industry, contributing to the high-quality development of China's cell industry.
The release of T/CRHA 041—2024 "General Requirements for Human-Derived Cell Storage Services" will not only help standardize the human-derived cell storage services market and improve service quality, but will also help drive the healthy development of the entire cell therapy industry. As an important participant in and driver of the industry, Beike Biotech will continue to leverage its technological advantages and innovation capabilities to contribute more wisdom and strength to industry standardization and development.
